Phraxis Inc.
EndoForce™ Connector, a medical device for endovascular venous anastomosis in renal interventions
- Sector
- Medtech
- Headquarters
- Minneapolis, MN
- Founded
- 2008
- Latest Form D
- $6.7M, Dec 2023
- Total capital
- $14.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $14.6M
- 7 Form D · last Dec 2023
- 34 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 8 pending · first 2020
- Rank in peer group#337 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$6.7M
- Offering registeredForm D · SEC · 6th filing$4.5M
- Private capital raisedForm D · SEC · 5th filing$5.6M
- Private capital raisedForm D · SEC · 4th filing$1.5M
- Private capital raisedForm D · SEC · 3rd filing$50K
- Private capital raisedForm D · SEC · 2nd filing$200K
- Private capital raisedForm D · SEC · 1st filing$600K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#337 · top 30%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Alexander B. YevzlinResearcherExecutive Officer, DirectorLinked by 1 patent
- Alexander J. Yevzlin, M.D.DirectorNamed in SEC Form D filings
- Cindy S. SetumExecutive OfficerNamed in SEC Form D filings
- Geoffrey S. BeecherExecutive OfficerNamed in SEC Form D filings
- James B. Hickey, Jr.Executive Officer, DirectorNamed in SEC Form D filings
- John S. RappeDirectorNamed in SEC Form D filings
Show all 14 people
- John J. SeabergDirectorNamed in SEC Form D filings
- John B. ZentgrafDirectorNamed in SEC Form D filings
- Leota S. PearsonExecutive OfficerNamed in SEC Form D filings
- Michael J. KallokExecutive Officer, DirectorNamed in SEC Form D filings
- Michael J. Kallok, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
- Paul Chase RobinsonExecutive OfficerNamed in SEC Form D filings
- Shelley B. OlsenExecutive OfficerNamed in SEC Form D filings
- Terry S. LitchfieldDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 12- GrantedEnd To End Anastomotic ConnectorUSPTOUS 12,672,875
- GrantedVenous Anchor Devices Forming An Anastomotic ConnectorUSPTOUS 11,020,215
- PendingOne Piece Anastomotic ConnectorUSPTOApplication 16957465
Show all 12 patent records
- End To End Anastomotic ConnectorJul 7, 2026 · US 12,672,875Granted
- Venous Anchor Devices Forming An Anastomotic ConnectorJun 1, 2021 · US 11,020,215Granted
- One Piece Anastomotic ConnectorMar 11, 2021 · Application 16957465Pending
- Arterial And Venous Anchor Devices Forming An Anastomotic Connector And System For DeliveryNov 17, 2020 · US 10,835,366Granted
- Arterial Anchor Devices Forming An Anastomotic ConnectorSep 29, 2020 · US 10,786,346Granted
- One Piece Anastomotic ConnectorApplication PCTUS2019017200Pending
- Arterial And Venous Anchor Devices Forming An Anastomotic Connector And System For DeliveryApplication PCTUS2012067561Pending
- Anastomotic ConnectorApplication PCTUS2012042666Pending
- Arterial Venous Spool AnchorApplication PCTUS2012042639Pending
- End To End Anastomotic ConnectorApplication PCTUS2019016970Pending
- Anastomotic Connector And System For DeliveryApplication PCTUS2012042688Pending
- End To End Anastomotic ConnectorApplication 62628043Pending
Related companies, and why
- SANAHEAL, INC.Similar federal contract value in Medtech · null in contracts
- PHOENIX S AND T, INC.Similar federal contract value in Medtech · null in contracts
- Cognext Diagnostics LLCSimilar federal contract value in Medtech · null in contracts
- CEROVATIONS LLCSimilar federal contract value in Medtech · null in contracts
- TRULY TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
- Immunarray USA, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .